Abstract
BackgroundProduction of human monoclonal antibodies that shows broadly neutralising activity is needed for the prevention of HIV-1. Here we devised a novel approach and produced 11 different human scFvs against...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
